Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,466,529
-$1,039,181 QoQ
Shares Held
74,929
-0.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#441
of 2,266 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Mar 31, 2022CallValue
$53,505,000
CallShares
900,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aptus Capital Advisors, LLC holds $223,621,682 across 14 Drug Manufacturers - General names. GILD ranks #6 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
53,662 | $64,363,817 | |
| 2 | JNJ |
Johnson & Johnson
|
201,691 | $51,223,462 | |
| 3 | ABBV |
AbbVie Inc.
|
142,030 | $35,740,429 | |
| 4 | MRK |
Merck & Co., Inc.
|
201,987 | $25,955,329 | |
| 5 | AMGN |
Amgen Inc
|
42,764 | $15,485,699 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
74,929 | $9,466,529 | |
| 7 | PFE |
Pfizer Inc
|
365,411 | $8,799,096 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
134,318 | $7,739,403 |
All Filings in GILD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,466,529 | 74,929 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $10,505,710 | 75,380 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $9,792,442 | 79,782 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,555,880 | 77,080 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,500,561 | 22,554 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,092,533 | 18,675 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,690,463 | 18,301 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $692,769 | 8,263 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $545,723 | 7,954 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $641,743 | 8,761 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,948,252 | 61,082 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,583,480 | 61,162 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,885,159 | 63,386 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $340,177 | 4,100 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $397,485 | 4,630 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $273,841 | 4,439 | Shares | Sole | 2022-11-02 | |
| 2022-03-31 | $170,562 | 2,869 | Shares | Sole | 2022-05-04 | |
| 2022-03-31 | $53,505,000 | 900,000 | Call | Sole | 2022-05-04 | |
| 2020-06-30 | $206,737 | 2,687 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $282,219 | 3,775 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||